Usefulness of the valvuloarterial impedance to predict adverse outcome in asymptomatic aortic stenosis

DC FieldValueLanguage
dc.contributor.authorHachicha, Zeineb-
dc.contributor.authorDumesnil, Jean G.-
dc.contributor.authorPibarot, Philippe-
dc.date.accessioned2016-06-13T17:35:32Z-
dc.date.available10000-01-01-
dc.date.issued2009-09-08-
dc.identifier.issn0735-1097fr_CA
dc.identifier.urihttp://hdl.handle.net/20.500.11794/4988-
dc.description.abstractObjectives :This study was designed to examine the prognostic value of valvuloarterial impedance (Zva) in patients with aortic stenosis (AS). Background : We previously showed that the Zva is superior to standard indexes of AS severity in estimating the global hemodynamic load faced by the left ventricle (LV) and predicting the occurrence of LV dysfunction. This index is calculated by dividing the estimated LV systolic pressure (systolic arterial pressure mean transvalvular gradient) by the stroke volume indexed for the body surface area. Methods : We retrospectively analyzed the clinical and echocardiographic data of 544 consecutive patients having at least moderate AS (aortic jet velocity 2.5 m·s 1) and no symptoms at baseline. The primary end point for this study was the overall mortality regardless of the realization of aortic valve replacement (AVR). Results : Four-year survival was significantly (p 0.001) lower in the patients with a baseline Zva 4.5 mm Hg·ml 1·m2 (65 5%) compared with those with Zva between 3.5 and 4.5 mm Hg·ml 1·m2 (78 4%) and those with Zva 3.5 mm Hg·ml 1·m2 (88 3%). The risk of mortality was increased by 2.76-fold in patients with Zva 4.5 mm Hg·ml 1·m2 and by 2.30-fold in those with a Zva between 3.5 and 4.5 mm Hg·ml 1·m2 after adjusting for other risk factors and type of treatment (surgical vs. medical). Conclusions : Increased Zva is a marker of excessive LV hemodynamic load, and a value 3.5 successfully identifies patients with a poor outcome. These findings suggest that beyond standard indexes of stenosis severity, the consideration of Zva may be useful to improve risk stratification and clinical decision making in patients with AS. (J Am Coll Cardiol 2009;54:1003–11) © 2009 by the American College of Cardiology Foundationfr_CA
dc.languageengfr_CA
dc.publisherElsevier Biomedicalfr_CA
dc.subjectAortic valvefr_CA
dc.subjectAortic stenosisfr_CA
dc.subjectHypertensionfr_CA
dc.subjectArterial compliancefr_CA
dc.subjectMortalityfr_CA
dc.titleUsefulness of the valvuloarterial impedance to predict adverse outcome in asymptomatic aortic stenosisfr_CA
dc.typeCOAR1_1::Texte::Périodique::Revue::Contribution à un journal::Article::Article de recherche-
dcterms.bibliographicCitationJournal of the American College of Cardiology, Vol. 54 (11), 1003–1011 (2009)fr_CA
dc.audienceProfesseurs (Enseignement supérieur)fr_CA
dc.audienceÉtudiantsfr_CA
dc.audienceDoctorantsfr_CA
dc.audienceCardiologuesfr_CA
dc.audienceMédecinsfr_CA
dc.identifier.doi10.1016/j.jacc.2009.04.079fr_CA
dc.identifier.pubmed19729117fr_CA
dc.subject.rvmValvule semi-lunaire de l'ostium aortiquefr_CA
dc.subject.rvmAorte -- Rétrécissementfr_CA
dc.subject.rvmHypertension artériellefr_CA
dc.subject.rvmMortalitéfr_CA
dc.subject.rvmPronostics (Pathologie)fr_CA
rioxxterms.versionVersion of Recordfr_CA
rioxxterms.version_of_recordhttps://doi.org/10.1016/j.jacc.2009.04.079fr_CA
rioxxterms.projectMOP-82873fr_CA
rioxxterms.project.funder_nameirscfr_CA
bul.rights.periodeEmbargoInfinifr_CA
Collection:Articles publiés dans des revues avec comité de lecture

Files in this item:
Description SizeFormat 
Hachicha2009-11618.pdf
556.68 kBAdobe PDF    Request a copy
All documents in CorpusUL are protected by Copyright Act of Canada.